Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04789408 |
Title | Study Evaluating the Safety of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Gilead Sciences |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford Cancer Center | Stanford | California | 94305 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
The Ohio State University Wexner Medical Center/James Cancer Hospital | Columbus | Ohio | 43210 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | United States | Details | |
Institut Paoli-Calmettes | Marseille | 13009 | France | Details | ||
CHU de Toulouse Institut Universitaire du Cancer Toulouse Oncopole | Toulouse | 3110 | France | Details |